Radiobotics releases RBfracture version 2.5 with new clinician feedback and confidence scoring features

RBfracture version 2.5 introduces two new features designed to enhance transparency, usability, and collaboration with clinicians.

July 14, 2025 — Copenhagen, Denmark — Radiobotics, a leader in AI-powered trauma-detection, announced the release of RBfracture version 2.5. RBfracture v2.5 introduces two new features designed to enhance transparency, usability, and collaboration with clinicians.

RBfracture 2.5 introduces a new channel for clinical feedback

With this release, RBfracture Summary Reports now include a QR code which clinicians can use to submit study-specific feedback directly and securely. Users can scan the code to quickly submit feedback related to an individual study.

With the introduction of this feature, clinicians can provide Radiobotics a better understanding of real-world performance across diverse clinical environments.

“An immediate, structured feedback process will not only enhance RBfracture’s accuracy and performance — hopefully clinicians also feel closer to the Radiobotics team,” says Pavel Lisouski, co-founder and CTO at Radiobotics.

Confidence scoring for greater transparency and decision support

RBfracture v2.5 also introduces confidence scoring, a percent-based indicator of how certain RBfracture is in its assessment, for each detected finding.

“RBfracture v2.5 reflects our commitment to building trust in using AI in medical environments,” says Peter Ulvskjold, CEO at Radiobotics. “Bringing AI into high-stakes environments like the Emergency Department requires more than performance. It requires transparency and trust. And that’s exactly what these new features aim to deliver.”

About Radiobotics

Founded in 2017, Radiobotics, a Medimaps Group company, is an award-winning Danish MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusion.

Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, constraints, is reflected in its close collaboration with leading clinical institutions, including partnering with Oxford University Hospital (OUH) on the world’s first and largest randomised clinical trial evaluating radiology AI in urgent care as well as achieving NICE approval for use in urgent care settings across the NHS.

Media contact
Elyse Sims
Head of Marketing, Radiobotics

Share this press release

Latest news